This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Northwestern University, The George Washington University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2026
Title: Yeonsik Choi and Bioresorbable Cardiovascular Instruments
Introduction
Yeonsik Choi is an inventor associated with Evanston, Illinois. His work includes a patent for bioresorbable cardiovascular instruments designed to support cardiac and neurological therapies while addressing challenges associated with conventional implanted devices.
Latest Patents
Choi is named on 1 patent: “Bioresorbable Cardiovascular Instruments, and Operation and Fabrication Methods of Same.” The invention describes an implantable device for pacemaker, neuromodulator, or defibrillator therapy. It uses resonant inductive coupling to deliver power to target tissue, avoiding the need for an implanted battery or transcutaneous leads.
The device is designed to be thin, flexible, lightweight, and biocompatible. Its materials resorb through metabolic action and hydrolysis after a controlled period, allowing the device to disappear through natural biological processes once therapy is complete. Full implantation without percutaneous hardware may also reduce risks of infection and device dislodgement.
Career Highlights
Choi’s listed institutional affiliations include Northwestern University and The George Washington University. His patent reflects research into implantable medical technology and materials engineered to perform reliably during treatment and then resorb afterward.
Collaborations
Choi’s coworker is John A. Rogers, an inventor and researcher known for work in flexible and biointegrated electronics.
Conclusion
Yeonsik Choi’s patented bioresorbable cardiovascular instrument combines wireless power delivery with materials designed to disappear after use, offering an approach to implanted therapy that may reduce reliance on batteries, leads, and permanent hardware.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile